r Augmented inositol 1,4,5-trisphosphate (IP 3 ) receptor (IP 3 R2) expression has been linked to a variety of cardiac pathologies.
r The present study focuses on mechanisms of IP 3 R2-mediated sarcoplasmic reticulum (SR)-Ca 2+ release in ventricular excitation-contraction coupling under IP 3 R2-overexpressing conditions by studying intracellular Ca 2+ events.
r We report that, upon IP 3 R2 overexpression in ventricular myocytes, IP 3 -induced Ca 2+ release (IP 3 ICR) modulates the SR-Ca 2+ content via "eventless" SR-Ca 2+ release, affecting the global SR-Ca 2+ leak. Thus, IP 3 R2 activation could act as a SR-Ca 2+ gateway mechanism to escape ominous SR-Ca 2+ overload.
r Our approach unmasks a so far unrecognized mechanism by which "eventless" IP 3 ICR plays a protective role against ventricular Ca 2+ -dependent arrhythmogenicity.
Abstract Augmented inositol 1,4,5-trisphosphate (IP 3 ) receptor (IP 3 R2) function has been linked to a variety of cardiac pathologies including cardiac arrhythmias. The functional role of IP 3 -induced Ca 2+ release (IP 3 ICR) within ventricular excitation-contraction coupling (ECC) remains elusive. As part of pathophysiological cellular remodelling, IP 3 R2s are overexpressed and have been repeatedly linked to enhanced Ca 2+ -dependent arrhythmogenicity. In this study we test the hypothesis that an opposite scenario might be plausible in which IP 3 ICR is part of an Joaquim Blanch i Salvador received his BS and MS degrees in Biomedical Sciences and Biotechnology from the University of Barcelona. After graduating, he joined Professor Dr M. Egger's group in the Department of Physiology of the University of Bern as a PhD student. Combining electrophysiology techniques with confocal Ca 2+ imaging and molecular biology approaches, his research focuses on the study of intracellular Ca 2+ oscillations within cardiomyocytes in a framework of cardiac pathology.
Introduction
Sudden cardiac death due to arrhythmia is responsible for 10-30% of deaths among patients with hypertrophic cardiomyopathy (Ullal et al. 2016) . In cardiac hypertrophy, alterations in Ca 2+ -induced Ca 2+ release (CICR) and excitation-contraction coupling (ECC) have been associated with cardiac instability (Gusev et al. 2009 ). Thus understanding the underlying mechanisms essentially contributes to the development of novel treatment strategies. Ca 2+ release from the sarcoplasmic reticulum (SR) in ventricular cardiomyocytes is mediated by two Ca 2+ release channels: the ryanodine receptor type 2 (RyR2) and the inositol 1,4,5-trisphosphate receptor type 2 (IP 3 R2; Bers, 2002; Hohendanner et al. 2014) . While RyR2s play a central role in ventricular ECC, the contribution of functionally expressed IP 3 R2s under physiological and pathophysiological conditions is less well understood. In contrast to RyR2s, which are exclusively activated by Ca 2+ , IP 3 R2s are sensitive to Ca 2+ and IP 3 . The latter SR-Ca 2+ release mechanism has been established as IP 3 -induced Ca 2+ release (IP 3 ICR; Zima & Blatter, 2004; Harzheim et al. 2009 ). Intracellular IP 3 synthesis is triggered by a variety of vaso-and cardioactive hormones (e.g. endothelin-1, angiotensin II) by stimulating G protein-coupled receptors (GPCRs) that couple to phospholipase C, liberating IP 3 from phosphatidylinositol 4,5-bisphosphate (Proven et al. 2006; Berridge, 2009) .
Although the ratio of functionally expressed RyR2s versus IP 3 R2s is approximately 100:1, a modulatory function of IP 3 ICR in ventricular myocyte ECC has been suggested and is the subject of an ongoing controversial discussion (Lipp et al. 2000; Kockskämper et al. 2008) . In contrast to the physiological condition, a more pronounced role of IP 3 ICR in the framework of cardiac pathophysiology seems to be reasonable. It has been found that remodelling of ECC under various cardiac pathologies (e.g. cardiac hypertrophy, ischaemic dilated cardiomyopathy, atrial fibrillation, failing myocardium and hypertension) is associated with IP 3 R2s overexpression and, in this context, enhanced IP 3 ICR has been repeatedly linked to arrhythmogenicity (Zhang et al. 2002; Harzheim et al. 2009 Harzheim et al. , 2010 Nakayama et al. 2010; Signore et al. 2013) . Supporting evidence comes from the observation that endothelin-1 and angiotensin II -both GPCR agonists -have similar positive inotropic effects in ventricular myocytes, suggesting a role of IP 3 ICR in the regulation of cytosolic Ca 2+ homeostasis (Zima & Blatter, 2004) . In addition, RyR2-IP 3 R2 local bi-directional crosstalk mechanisms in cardiomyocytes have been recently described and may be involved in Ca 2+ -dependent arrhythmogenicity at the cellular level (Wullschleger et al. 2017) . Moreover, these studies support the concept of distinct RyR2-IP 3 R2 Ca 2+ signalling compartments within cardiomyocyteseither in the cytosol and/or in the nucleus -during pathophysiological signalling driven by IP 3 and IP 3 R2 (Wu & Bers, 2006; Drawnel et al. 2010) . In contrast, it has also been suggested that increased synthesis of IP 3 as well as IP 3 R2 expression, may be a common feature of cardiac pathologies but without having functional significance for the ECC mechanism (Cooley et al. 2013) .
At the subcellular level, synchronized and functionally clustered RyR2 openings result in "Ca 2+ sparks", the building blocks of global Ca 2+ transients in ventricular myocytes; analogously coordinated openings of clustered IP 3 R2s give rise to "Ca 2+ puffs" (Cheng et al. 1993; Yao et al. 1995) . Although similar, the distinct spatio-temporal characteristics of Ca 2+ puffs and Ca 2+ sparks and their pharmacological profile can be used for classification and separation of SR-Ca 2+ release events (Hohendanner et al. 2015) . Openings of singular and/or "misplaced" RyR2s or IP 3 R2s that do not belong to channel clusters may not generate detectable SR-Ca 2+ release events but can still contribute to the intracellular Ca 2+ homeostasis (Lipp & Niggli, 1996; Sobie et al. 2006; Brochet et al. 2011 ). Analogously to recently described "rogue" RyR2s, "rogue" IP 3 R2s may generate an "eventless" SR-Ca 2+ release flux which might have a significant impact on the total SR-Ca 2+ leak in ventricular myocytes without giving rise to localized Ca 2+ events . Among other factors, the open probability (P o ) of both IP 3 R2s and RyR2s and thus the SR-Ca 2+ leak, is critically controlled by SR luminal Ca 2+ (Nunn & Taylor, 1992; Terentyev et al. 2002) . Spontaneous increased RyR2 P o under SR-Ca 2+ overload results in asynchronous SR-Ca 2+ release (e.g. Ca 2+ waves) and may lead to delayed after-depolarizations, a major cause of ventricular tachyarrhythmias and sudden cardiac death (Keller et al. 2007; Liu et al. 2013) . Although largely outnumbered by RyR2s, overexpression of IP 3 R2s within cardiac pathology may render the latter receptor a more significant SR-Ca 2+ regulatory function. The present study focuses on potential mechanisms by which IP 3 R2 may have a Ca 2+ -dependent anti-arrhythmogenic function at the cellular level.
Our data in the present study reveal that stimulation of IP 3 ICR in freshly isolated ventricular myocytes from a cardiac-specific IP 3 R2-overexpressing mouse model leads to a decrease in asynchronous SR-Ca 2+ release, a decline in the SR-Ca 2+ content and subsequent decrease in pro-arrhythmic Ca 2+ wave occurrence, suggesting a potential anti-arrhythmic role of IP 3 ICR. Although under cellular remodelling conditions the SR-Ca 2+ content appears to be under active control of IP 3 ICR, no additional IP 3 R2-mediated local SR-Ca 2+ events (e.g. Ca 2+ puffs) were identified. Interestingly, study of the SR-Ca 2+ leak revealed a more prominent IP 3 R2-dependent component that controls the SR-Ca 2+ content. Thus, these results support the view that IP 3 ICR contributes to the total SR-Ca 2+ leak via "eventless" SR-Ca 2+ release. The underlying mechanism actively stabilizes the SR-Ca 2+ content and limits luminal RyR2 sensitization below the critical threshold for spontaneous Ca 2+ release thereby offering a protective mechanism against arrhythmias in ventricular myocytes.
Methods

Ethical approval
All experiments were approved by the State Veterinary Office of Bern (Switzerland), in accordance with Swiss Federal Animal Protection Law and were approved by the in-house ethical committee (Ref. BE96/16, Ref. EFWW0443) . For single myocyte isolation, mice were killed by cervical dislocation, hearts were extracted and perfused using the Langendorff perfusion technique. For transthoracic echochardiography measurements, mice were anaesthetized with 1-1.5% isoflurane, maintaining heart rate at 450-500 beats min −1 . Following data acquisition, mice were monitored until recovered from anaesthesia.
Cardiac-specific IP 3 R2-overexpressing mouse model
Mouse lines FVB-Tg(Myh6/tet0-Itpr2)3.11Jmol/J (The Jackson Laboratory, Bar Harbor, ME, USA) and FVB.CG-Tg(MyH6-tTA)6Smbf/J (Jacksons) were crossbred to generate the cardiac-specific IP 3 R type 2 (IP 3 R2) overexpressing mouse model (TG; Nakayama et al. 2010) . In the following, wild-type (WT) will be a synonym for ventricular myocytes isolated from WT mice and transgene (TG) for cells from IP 3 R2-overexpressing mice. Genotype was assessed via conventional polymerase chain reaction. Primers used include: for IP 3 R2 5 -CTTTCATCGGATGCCTGCCT-3 and 5 -TTGGGAGGCCAAGGTGGGTA-3 forward and reverse, respectively; and for tetracycline transactivator (tTA) 5 -CGCTGTGGGGCATTTTACTTTAG-3 and 5 -CATGTCCAGATCGAAATCGTC-3 forward and reverse, respectively. Heart and body weights (mg g −1 ) were determined at 5 months of age. All mice were fed with doxycycline-containing food (0.2 g kg −1 , Envigo, Füllinsdorf, Switzerland) during pregnancy and until 4 weeks of age.
Echocardiography
Transthoracic echocardiography was performed using a 30 MHz probe and the Vevo 2100 Ultrasound machine (VisualSonics, Bothell, WA, USA). All mice were anaesthetized with 1-1.5% isoflurane. The heart was imaged in 2-D mode on a parasternal long-axis view from where an M-mode cursor was positioned perpendicular to the interventricular septum and the posterior wall of the left ventricle. Echocardiographies were performed at the Cardiovascular Assessment Facility (CAF, Lausanne, Switzerland).
RNA and protein analysis
Animals were killed by cervical dislocation and tissues from ventricle, atria, aortic smooth muscle, femoral skeletal muscle and brain were excised, washed and snap-frozen in liquid nitrogen. For western blot analysis, ventricular tissue was ground in extraction buffer (1x Protease Inhibitor (04693159001, Sigma-Aldrich Chemie, Buchs, Switzerland) in NP40 extraction buffer, Invitrogen, Thermo Fisher Scientific, Reinach, Switzerland) for 30 min. Samples were centrifuged at 1400 g for 10 min at 4°C to obtain the supernatant. Following quantification J Physiol 596.18 by the bicinchoninic acid assay (BCA) method, 25 μg per lane of protein in loading solution (10% glycerol, 5% β-mercaptoethanol, 43% SDS, 62.5 mM Tris, 6 M urea) were loaded in 4-20% pre-cast gel (Bio-Rad, Basel, Switzerland) and run for 55 min at 200 V. Samples were transferred to PVDF membranes at 100 mA and 4°C overnight. After PBS washing steps, membranes were blocked for 1 h at room temperature (RT) in blocking solution (5% milk in PBS). Membranes were incubated with primary antibodies anti-IP 3 R2 (1:5000 KM1083, kindly provided by Prof. Dr K. Mikoshiba; Sugiyama et al. 1994) , anti-RyR2 (1:2000 ab2827, Abcam, Cambridge, UK) or anti-GAPDH (1:100,000 10R-G109A, Fitzgerald, Acton, MA, USA) in primary antibody solution (PBS-Tween, 0.5% milk). Secondary antibody anti-mouse Alexa 790 (1:100,000, ThermoFisher Scientific, Reinach, Switzerland) was applied in secondary antibody solution (PBS-Tween, 0.5% milk, 0.01% SDS) for 1 h at RT. Imaging was performed on an Odyssey set-up and images were analysed using GelAnalyzer. Full western blot images are available upon request.
Total RNA was extracted from snap-frozen mice tissues with NucleoSpin RNA Plus kit (Macherey-Nagel, Oensingen, Switzerland) and concentrations were determined with a NanoDrop 2000c (ThermoFisher Scientific). RT-qPCR was performed by loading 10 ng of sample in an Eco Real-Time PCR system (Illumina, Cambridge, UK) using KAPA SYBR FAST One-Step Universal kit (LabGene, Châtel-Saint-Denis, Switzerland) in accordance with the manufacturers' instructions. Primers used include: ITPR2 primer pair (M Itpr2 3, Sigma) and β-2-microglobulin primers (forward FM1 B2m, and reverse RM1 B2m, Sigma). ITPR2 gene relative expression was normalized to reference gene β-2-microglobulin.
C q was calculated and used for statistical analysis. TG data are shown normalized to their respective WT tissue (norm.).
Ventricular myocyte isolation
Animals were killed at 5 months of age by cervical dislocation. Ventricular cardiomyocytes were isolated in Tyrode Ca 2+ -free solution with the Langendorff perfusion technique with collagenase type II (Worthington) and Protease type XIV (Sigma). Extracellular Ca 2+ was slowly increased to physiological concentration (1.8 mM).
Solutions and chemicals
Ventricular cardiomyocytes were permeabilized with 0.05% escin (Sigma). Cells were kept in final solution containing (mM): 120 potassium aspartate (KAsp), 3 K-ATP, 3.734 MgCl 2 , 0.5 EGTA, 10 phosphocreatine, 10 HEPES and 0.05 Fluo-3 5K (Biotium), with the addition of 5 U L −1 creatine phosphokinase (pH 7.4, 310 mOsm L −1 ). Free-[Ca 2+ ] was measured using Indo-1 AM (Molecular Probes, Eugene, OR, USA) in a NanoDrop fluorospectrometer and adjusted to 70 nM. Cells were plated using Cell-Tak (Corning, Fisher Scientific, Schwerte, Germany)-coated coverslips. Pharmacological interventions include 10 μM IP 3 -salt (IP 3 , SiChem, Bremen, Germany), 2 μM 2-aminoethoxydiphenyl borate (2-APB, Calbiochem) and 20 mM caffeine (Sigma). Reports suggest that 2-APB at higher concentrations than that used in the present study may have secondary effects in other intracellular components besides blocking IP 3 R (Maruyama et al. 1997; Ascher-Landsberg et al. 1999; Peppiatt et al. 2003) . In our hands, application of 2 μM 2-APB in WT cells -in the absence of IP 3 stimulation -returned no unspecific effects. To ensure that the responses seen with 2-APB were due to IP 3 R block, 3 μM xestospongin C (XeC, Focus Biomolecules) was used as an alternative IP 3 R blocker. We are aware that both blockers used in our study do not have a 100% selectivity; however, the combination of both is currently the best option for a pharmacological separation of IP 3 effects.
Intact myocytes were loaded at RT with 5 μM Fluo-3 AM (Biotium, Fremont, CA, USA) for 30 min, plated in Cell-Tak-coated coverslips and kept in extracellular solution containing (mM): 140 NaCl, 5 HEPES, 1.1 MgCl 2 , 5.4 KCl, 10 glucose and 1.8 CaCl 2 . For Na + and Ca 2+ free solution, NaCl was replaced by 140 LiCl and 0.5 EGTA. To reach steady state cells were field stimulated for 30 s at a frequency of 1 Hz. The following pharmacological agents were used: 100 nM endothelin-1 (ET-1, Sigma), 2 μM 2-APB, 3 μM XeC, 1 mM tetracaine (tet, Sigma) and 10 mM caffeine (Sigma). 
Confocal Ca 2+ imaging
To assess intracellular Ca 2+ changes, Fluo-3 was excited at 488 nm wavelength of an argon laser and fluorescence was collected at 525 nm in line-scan mode (2 ms per line) with a photomultiplier tube (PMT) on a MicroRadiance laser scanning confocal microscope (Bio-Rad, Watford, UK) or alternatively a FluoView 1000 (Olympus, Volketswil, Switzerland) with a solid-state laser (Sapphire, Coherent, Santa Clara, CA, USA).
Data analysis and statistics
Raw line-scan data from permeabilized myocytes were analysed using the ImageJ (NIH) plug-in SparkMaster to obtain Ca 2+ spark frequency (Ca 2+ sparks (100 μm) -1 s -1 ), amplitude (Amp, change in fluorescence relative to the fluorescence background ( F/F 0 )), full-width at amplitude half-maximum (μm, FWHM), full duration at amplitude half-maximum (ms, FDHM), full duration (ms), exponential time constant of the spark decay (τ decay , ms) and time to peak (ms). Spark mass was calculated as Amplitude × 1.206 × (FWHM) 3 (Hollingworth et al. 2001) ; Ca 2+ released via Ca 2+ sparks was estimated as the product of the spark frequency and spark mass. Spark frequency data are presented as 100 sparks μm −1 s −1 or normalized to the vector where indicated (norm.). Data analysis was performed using the softwares ImageJ (NIH, Bethesda, MD, USA) and Igor Pro (WaveMetrics, Lake Oswego, OR, USA).
Data are presented as box (25-75 percentiles) and whisker (10 and 90 percentiles) plots; outliers are highlighted. Data within tables are presented as mean ± standard deviation (SD). Normal distribution of the data was assessed by D'Agostino's K 2 test. Statistical comparison was performed via one-way ANOVA for multi-parametric comparison followed by Dunnett's test or paired or unpaired Student's t test. Binary data were tested by the χ 2 test. Number of animals (N), cells (n), Ca 2+ events (n e ) and statistical results are indicated in the figure legends.
Results
Cardiac IP 3 R2 overexpression induces cardiac remodelling both at cellular and organ levels
A cardiac-specific IP 3 R2-overexpressing mouse model (TG; Nakayama et al. 2010) has been used to mimic cardiac hypertrophy occurring in patients (Harzheim et al. 2009 ). In addition, the strategy to tune one element within a complex cellular remodelling situation to extreme could unmask an otherwise potentially invisible regulatory mechanism. The TG mice display a significantly higher heart weight to body weight ratio when compared to their wild-type littermates (WT, 7.75 ± 0.92 mg g −1 vs. TG 10.6 ± 1.69 mg g . TG mice display cardiac remodelling at both cellular and organ levels A, heart weight (mg)/body weight (g) of WT (N = 5) and TG (N = 9) hearts at 5 months of age ( * * P < 0.01; Student's t test). B, ITPR2 gene relative expression in various tissues depicted as C q and normalized to WT. β-2-Microglobulin was used as reference gene (ventricle and atria N = 4 each; brain, smooth and skeletal muscle N = 3 each). C, relative IP 3 R2 and RyR2 protein expression in TG ventricular tissue when compared to WT and normalized to GAPDH. Box plots display IP 3 R2 (left) and RyR2 (right) ( * P < 0.05, * * P < 0.01; N = 4 each; Student's t test). A cardiac hypertrophic phenotype was confirmed via transthoracic echocardiography (Table 1) , which revealed greater interventricular septum (IVS, 0.78 ± 0.08 mm WT vs. 0.93 ± 0.09 mm TG; N = 4, 6; P = 0.039) and left ventricular posterior wall thickness (LVPW, 0.78 ± 0.07 mm WT vs. 0.94 ± 0.11 mm TG; P = 0.033) in TG hearts when compared to WT. Figure 1B shows an increase in the relative expression of ITPR2 mRNA (IP 3 R2 encoding gene) levels in both ventricular and atrial tissue. A minor ITPR2 expression increase was detected in smooth and skeletal muscle but was absent in brain tissue. Accordingly, western blot analysis revealed a 12.72 (±2.97)-fold increase in IP 3 R2 protein synthesis (N = 4 each; P = 0.001; Fig. 1C , left) in ventricle. In addition and in line with other reports (Zhao et al. 2007 ), RyR2 protein level was significantly decreased in TG ventricular tissue (61.73 ± 0.24%; N = 4 each; P = 0.012; Fig. 1C wave occurrence (5.5% WT vs. 46% TG; P < 0.001; Fig. 2C ).
Compared to control, ET-1 (100 nM, after 7-10 min application) triggered an increase in Ca 2+ transient Values are means ± SD. Spatio-temporal characteristics analysed include Ca 2+ transient amplitude ( F/F 0 ), tau decay (τ decay , ms), time to 50% amplitude (T50, ms), fractional SR-Ca 2+ release (a.u.) and SR-Ca 2+ content ( F/F 0 ) from WT and TG ( * P < 0.05, * * P < 0.01 vs. control; ‡ P < 0.05, ‡ ‡ P < 0.01, ‡ ‡ ‡ P < 0.001 vs. WT). Number of animals (N) and cells (n) are indicated below each condition as (n, N).
amplitude (3.25 ± 1.17 F/F 0 ET-1; n = 11; P = 0.001; Fig. 2B , upper left), SR-Ca 2+ content (5.06 ± 1.81 F/F 0 ET-1; P = 0.013; Fig. 2B , upper right) and Ca 2+ wave occurrence (27.78% ET-1; P = 0.035; Fig. 2C ) in WT cardiomyocytes, but surprisingly this effect was absent in IP 3 R2-overexpressing cells ( Fig. 2B and C) . In contrast, ET-1 induced a 21.72% decrease in Ca 2+ wave occurrence only in TG myocytes ( Fig. 2C ; n = 16; P < 0.001).
In WT cardiomyocytes, block of IP 3 R2 by 2-aminoethoxydiphenyl borate (2-APB, 2 μM) or xestospongin C (XeC, 3 μM) returned no detectable changes in the analysed Ca 2+ responses. In contrast, under IP 3 R2-overexpressing conditions, blockade of IP 3 R2 led to increases in Ca 2+ transient amplitude (3.04 ± 1.28 F/F 0 2-APB and 2.95 ± 0.78 F/F 0 XeC; n = 14, 11; P = 0.033, 0.018; Fig. 2B , lower left) with concomitantly higher SR-Ca 2+ content (4.57 ± 1.18 F/F 0 2-APB and 4.11 ± 1.08 F/F 0 XeC; P = 0.007, 0.08; Fig. 2B , lower right). Finally, block of IP 3 R2 by 2 μM 2-APB abolished ET-1-mediated effects on cellular arrhythmogenicity both in WT and TG myocytes (Fig. 3) . In other words, ET-1 stimulation fails to alter the Ca 2+ wave occurrence while IP 3 R remains blocked (Fig. 3) .
To further study ET-1-mediated effects, estimation of sarco(endo)plasmic reticulum Ca 2+ -ATPase (SERCA) and Na + -Ca 2+ exchanger (NCX) relative contributions to the total Ca 2+ transient decay was approached (Fig. 4) . -4 = 13, 11, 16, 15 ; N of groups 1-4 = 4, 3, 3, 3) and TG myocytes (n of groups 1-4 = 14, 16, 14, 11; N of groups 1-4 = 4, 4, 3, 3; * P < 0.05, * * P < 0.01 vs. control; ANOVA followed by Dunnett's test). C, Ca 2+ wave occurrence (%) calculated as the portion of cardiomyocytes displaying Ca 2+ waves within the 10 s rest period ( * P < 0.05, * * * P < 0.001 vs. control; ‡ ‡ ‡ P < 0.001 vs. WT; N = 3-4, n = 9-21; χ 2 test).
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capacity of the cell, and to the Ca 2+ transient (T) decay in the presence of 10 mM caffeine to assess NCX contribution (Fig. 4A, left panel) . SERCA and NCX (orange) contributions to the twitch decline (%) were calculated as: ((1/T twitch ) − (1/T caffeine ))/(1/T twitch ) and (1/T caffeine )/(1/T twitch ), respectively. In control conditions (Fig. 4A, right panel) , TG myocytes display a higher SERCA contribution when compared to WT ( * * P < 0.01; N = 4 each, n = 13, 14). An increase in SERCA contribution to the twitch Ca 2+ decline upon 100 nM ET-1 stimulation was seen only in WT ventricular myocytes ( Fig. 4Ba ; ‡ ‡ P < 0.01; N = 4, 3; n = 13, 11 (Fig. 5B, right, and C) . In line with the concept that IP 3 ICR can boost CICR (e.g. Ca 2+ sparks), in WT ventricular cardiomyocytes IP 3 -salt (10 μM) evoked a significant increase in CaSpF (24.2%; n = 22; P = 0.006; ( Table 3 ). This response was sensitive both to 2 μM 2-APB and 3 μM XeC (Fig. 5Da) . In contrast to the native situation, in IP 3 R2 overexpressing cardiomyocytes, IP 3 induced a 25.17% decrease of the CaSpF (P = 0.015; n = 25, 13; P = 0.015; Fig. 5Db , right) along with a reduction of the SR-Ca 2+ content (4.17 ± 0.48 F/F 0 control vs. 3.56 ± 0.57 F/F 0 IP 3 ; P = 0.012; Fig. 5Db , left) 2-4 min after application. Both effects were sensitive to XeC and 2-APB.
To elucidate how the SR-Ca 2+ content can be reduced even with a lower number of Ca 2+ sparks, individual Ca 2+ events were analysed. Spatio-temporal Ca 2+ event analysis revealed no differences in individual parameters between Ca 2+ events observed in WT and TG cells upon direct IP 3 stimulation (Table 3) . Recently, we reported that multi-parametric analysis of single Ca 2+ events upon similar pharmacological interventions as presented in the current study can be used as a tool to differentiate among Ca 2+ sparks and Ca 2+ puffs in permeabilized atrial myocytes (Wullschleger et al. 2017) . Hence, we repeated the analysis for the data presented here. Figure 6 shows single Ca 2+ events in control conditions and upon IP 3 application plotted according to their individual fluorescence amplitude and full duration at amplitude half-maximum (FDHM). IP 3 application did not induce any detectable differences either in WT ( Fig. 6Aa ; n e = 195, 374) or TG myocytes ( Fig. 6Ab; n e = 443, 269) and TG myocytes (n of groups 1-4 = 25, 13, 11, 10; N of groups 1-4 = 8, 3, 3, 3; * P < 0.05, * * P < 0.01 vs. control; † P < 0.05, † † P < 0.01 vs. IP 3 ; ANOVA followed by Dunnett's test). Following cell permeabilization and plating, a representative line-scan was recorded to assess Ca 2+ events in control conditions. Pharmacological effects were assessed 2-4 min post-intervention (10 μM IP 3 -salt, 2 μM 2-APB, 3 μM XeC). Parameters analysed include Ca 2+ spark amplitude ( F/F 0 ), full duration at amplitude half-maximum (FDHM, ms), full duration (ms), full width at amplitude half-maximum (FWHM, μm), spark mass (a.u.), tau decay (τ decay , ms) and time to peak (ms) for WT and TG ( * * P < 0.01, * * * P < 0.001 vs. control; † P < 0.05, † † † P < 0.001 vs. IP 3 -salt; ANOVA followed by Dunnett's test). N and n are indicated below each condition as (n, N).
( Fig. 6Ba ), but evoked a reduction in TG cells (Fig. 6Bb) . Both effects are presumably due to the differences in CaSpF induced by the application of IP 3 . The discrepancy between reduced SR-Ca 2+ content and the total amount of Ca 2+ released observed during IP 3 stimulation in TG cardiomyocytes can neither be explained by the number of detected events nor the spatio-temporal characteristics of individual Ca 2+ events. release (Chen et al. 2014) . Since a discrepancy between CaSpF and SR-Ca 2+ content was evident, we hypothesized a contribution of IP 3 ICR via "eventless" SR-Ca 2+ release. We performed a series of SR-Ca 2+ leak protocols (Fig. 7A) in the presence of RyR2 antagonists and/or IP 3 R2 agonists/antagonists to assess a potential contribution of "eventless" IP 3 ICR on the total SR-Ca 2+ leak (Shannon et al. 2002) . Figure 7B shows zoomed-in examples with the corresponding fluorescence profiles for WT and TG myocytes (left and right, respectively) showing the RyR2 contribution to the total SR-Ca 2+ leak estimated as the difference ( Ca 2+ cyt = F tet − F 0 ) between the fluorescence before (F 0 ) and after RyR2 block (F tet Figure 7C shows that compared to WT, TG cells display a lower Ca Figure 8A shows representative SR-Ca 2+ leak profiles in the tested conditions (control, ET-1, ET-1 + 2-APB and 2-APB) for WT and TG ventricular myocytes. Figure 8Ba exhibits the aforementioned traces from the different conditions overlapped for each animal group (WT and TG, above and below, respectively). Finally, Fig. 8Bb displays the fitted samples according to cell type (WT or TG, above and below, respectively) and pharmacological intervention (control vs. ET-1, left and right, respectively) and indicates the SR-Ca 2+ leak portion corresponding to RyR or IP 3 R.
In WT myocytes, 100 nM ET-1 induced a 31.25% decrease in Ca 2+ cyt (n = 20; P = 0.011; Fig. 8C , top left panel), which was sensitive to 2 μM 2-APB. 2-APB alone did not significantly affect any of the tested parameters. In addition, ET-1 induced IP 3 -independent increases of the SR-Ca 2+ content but not the Ca 2+ transient amplitude (Fig. 8C, top middle and right panels,  respectively) .
Surprisingly, in TG cells, ET-1 application resulted in no detectable Ca 2+ cyt changes (Fig. 8C , bottom left panel) and non-significant decreases of the Ca 2+ transient amplitude and the SR-Ca 2+ content (Fig. 8C , bottom middle and left panels, respectively). In contrast, IP 3 R2 block by 2-APB resulted in a large decrease of the Ca 2+ cyt both in the presence and absence of ET-1 (Fig. 8C , bottom left panel) together with increases in the SR-Ca 2+ content (Fig. 8C, bottom wave occurrence.
Discussion
Our results obtained in ventricular cardiomyocytes reveal that, upon IP 3 R2 overexpression, IP 3 ICR stimulation leads to a decrease in RyR2 activity together with a decline in SR-Ca 2+ content, indicating that IP 3 R2 activation can act as a SR-Ca 2+ gateway mechanism to escape ominous SR-Ca 2+ overload and subsequent unsynchronized SR-Ca 2+ release. Our approach unmasks a so far unrecognized mechanism by which IP 3 ICR modulates SR-Ca 2+ content via "eventless" SR-Ca 2+ leak and effectively restores cardiomyocyte Ca 2+ homeostasis. These observations are based on a cardiac-specific IP 3 R2-overexpressing mouse model that mimics at least in part cardiac hypertrophy in patients (Nakayama et al. 2010) . Cardiac remodelling is a complex process that affects a broad range of intracellular Ca 2+ signalling components. TG myocytes are characterized by increases in IP 3 R2 expression together with RyR2 down-regulation, a phenomenon known for various cardiac diseases (Go et al. 1995; Domeier et al. 2012; Zima et al. 2014) .
IP 3 is known to significantly contribute to a variety of intracellular Ca 2+ signalling mechanisms by functionally exercising as a secondary messenger that interconnects extracellular signals to numerous subcellular processes. In ventricular myocytes, IP 3 Rs are preferentially located within the nuclear envelope and are found at a lower extent in the SR membrane (Bare et al. 2005) . While nuclear IP 3 ICR has been linked to the modulation of gene expression (Higazi et al. 2009 ), the contribution of SR-IP 3 Rs in ventricular ECC under physiological conditions remains controversial (Zhang et al. 2002; Harzheim et al. 2009 Harzheim et al. , 2010 Nakayama et al. 2010; Cooley et al. 2013; Signore et al. 2013) . Whether and in which direction enhanced IP 3 ICR may effectively modulate cardiac ECC in pathophysiological conditions warrants further investigation.
Ca
2+ wave occurrence is controlled by IP 3 ICR
In the myocardium, the amplitude of global Ca 2+ signals is locally controlled by Ca 2+ influx through L-type Ca release, these oscillations have been found to play a fundamental role in the generation of cardiac arrhythmias. At the cellular level, Ca 2+ oscillations originating from spontaneous SR-Ca 2+ release channel openings often manifest as Ca 2+ waves that travel from release junction to release junction in an unsynchronized manner. This process can be described as a "fire-diffuse-fire" mechanism (Keizer et al. 1998) . In this scenario, aberrant SR-Ca 2+ releases can substantially increase cytosolic Ca 2+ levels and trigger delayed afterdepolarizations, a major source for ventricular tachyarrhythmias (Lipp & Niggli, 1993) . A contribution of IP 3 ICR to the genesis of Ca 2+ -dependent arrhythmias has been suggested for some time (Zhang et al. 2002; Zima & Blatter, 2004; Kockskämper et al. 2008; Harzheim et al. 2009; Nakayama et al. 2010) . Our observations in wild-type cells (WT) are in agreement with this concept. Under control conditions we found an increase in SR-Ca 2+ release activity triggered by stimulation of the IP 3 pathway in the shape of Ca 2+ waves or Ca 2+ sparks. The use of G-protein coupled receptor (GPCR) agonists (e.g. ET-1) leads to the intracellular synthesis of IP 3 together with activation of protein kinase C (PKC). Although the positive inotropic action of ET-1 in ventricular myocytes is generally accepted, the underlying mechanisms are controversial, while numerous cellular targets are involved (Braz et al. 2004; Li et al. 2005; Domeier et al. 2012; Smyrnias et al. 2018) . In our hands, the inotropic responses triggered by ET-1 in WT cells (Figs 4 and 7) might be partially mediated by PKC during the ET-1/GPCR pathway stimulation. In the presence of ET-1, the SR-Ca 2+ leak increases together with the SR-Ca 2+ content; this discrepancy could be explained by the positive inotropic PKC-related effects on the LTCCs. As a consequence, increased Ca 2+ influx and SERCA activity during the pacing protocol may lead to the observed increased SR-Ca 2+ content (Fig. 2) . This may also have some relevance for the leak protocol (Fig. 7) . Interestingly, application of 2-APB in the presence of ET-1 restores the SR-Ca 2+ leak to basal levels, while the SR-Ca 2+ content remains elevated (Fig. 8) . In other words, the leak effect trigged by ET-1 is IP 3 R dependent. In addition, the ET-1-triggered arrhythmogenic responses on a cellular level can be reversed by IP 3 R2 block excluding significant PKC-dependent side effects (e.g. LTCCs, NCX) and indicating that IP 3 ICR seems to be the main mechanism responsible for the induced arrhythmic responses.
Analogously, the increase in Ca 2+ spark and Ca 2+ wave occurrence upon IP 3 stimulation may be partly explained by a functional bi-directional interaction between IP 3 R2 and RyR2 (Wullschleger et al. 2017) . Therefore, IP 3 ICR may directly trigger and/or amplify CICR resulting in the initiation and/or propagation of Ca 2+ waves. Under conditions of pathophysiological stress and the associated increased IP 3 R2 expression, the scenario given above may be fundamentally altered. Neurohumoral GPCR stimulation (e.g. via ET-1) serves as a positive inotropic reserve that partially functions via IP 3 ICR activation. This may include sensitization of RyR2 to activating ("triggering") cytosolic Ca 2+ together with increases in SR-Ca 2+ load, events that cooperatively increase single RyR2 channel open probability (P o ) and hence the tendency to develop arrhythmogenic Ca 2+ waves (Domeier et al. 2008) . Hence activation of GPCR via ET-1 unfolds a positive inotropic reserve at the expense of increased spontaneous SR-Ca 2+ release events. In line with this scenario, under increased IP 3 R2 expression, an even higher probability of Ca 2+ wave occurrence compared to the wild-type situation would be expected. Surprisingly, the opposite response was evident: activation of IP 3 ICR in conditions of IP 3 R2 overexpression (TG) resulted in a decrease rather than an increase in Ca 2+ wave occurrence. Furthermore, block of IP 3 R2 increased the SR-Ca 2+ content, suggesting an inherent regulatory role of IP 3 ICR in the control of the SR-Ca 2+ content. Thus, under conditions of enhanced IP 3 ICR, we hypothesized a secondary regulatory mechanism operating through IP 3 ICR activation and resulting in the reduction of Ca 2+ wave occurrence.
Global cytosolic Ca 2+ waves are composed of the temporal and spatial summation of individual CICR events (Ca 2+ sparks) that occur by spontaneous but concerted openings of RyR2 clusters (Cheng et al. 1993) . Analogously, IP 3 R2s are organized in clusters prerequisite to the generation of local Ca 2+ events known as Ca 2+ puffs (Yao et al. 1995 (Hohendanner et al. 2015; Wullschleger et al. 2017) . Recently we showed that, under similar experimental conditions, IP 3 application to permeabilized atrial myocytes triggered the appearance of a group of Ca 2+ events that can be identified and classified -via multi-parametric analysis of single Ca 2+ event properties -as IP 3 R2-mediated Ca 2+ puffs. In the present study, however, multi-parametric analysis of Ca 2+ event characteristics from permeabilized ventricular myocytes (Fig. 6A) The local SR-Ca 2+ release carried via stochastic opening of SR-Ca 2+ release channels independent from the beat-to-beat ECC mechanism is known as SR-Ca 2+ leak. The luminal SR-Ca 2+ has been shown to be a major regulatory factor controlling Ca 2+ release channel P o , hence the SR-Ca 2+ leak (Terentyev et al. 2002; Keller et WT and TG cell responses (left and right, respectively) . Intact ventricular myocytes were electrically paced for 30 s at 1 Hz to reach steady state. Tyrode solution was rapidly switched to a 0 Na + , 0 Ca 2+ solution for 15 s prior to addition of 1 mM tetracaine (tet). Finally, SR-Ca 2+ content was assessed (10 mM caffeine, Caff). B, representative zoomed-in confocal line-scan images (from dotted box in A) of WT and TG cell responses (right) in control conditions with the corresponding fluorescence profiles (left). For illustrative purposes each plot is shown overlapping with a trace corresponding to the fit of a single exponential decay function. SR-Ca 2+ leak (as Ca 2+ cyt ) was estimated by approaching the difference between fluorescence before (F 0 ) and after RyR2 block (F tet , Ca 2+ cyt = F tet − F 0 ). C, compared to WT, TG cells display a smaller Ca 2+ cyt (−0.16 ± 0.06 F/F 0 WT vs. −0.05 ± 0.07 F/F 0 TG; P < 0.001), larger Ca 2+ transients (1.95 ± 0.78 F/F 0 WT vs. 3.18 ± 0.99 F/F 0 TG; P = 0.002) with enhanced fractional SR-Ca 2+ release (0.51 ± 0.13 a.u. WT vs. 0.69 ± 0.22 a.u. TG; P = 0.011) and SR-Ca 2+ content (3.84 ± 1.62 F/F 0 WT vs. 4.75 ± 1.39 F/F 0 TG; P = 0.075; * P < 0.05, * * P < 0.01, * * * P < 0.001 vs. WT; n = 10, 16, N = 4 each; Student's t test). -4 = 16, 14, 21, 28 ; N of groups 1-4 = 4, 3, 3, 4) groups upon pharmacological intervention ( * P < 0.05, * * P < 0.01 vs. control; † P < 0.05, † † † P < 0.001 vs. ET-1; ANOVA followed by Dunnett's test). Regarding the leak/load protocol, interpretation of the data is less straightforward than expected. Strong evidence of pronounced SR-Ca 2+ leak mediated by IP 3 ICR is shown by IP 3 R block (2-APB) in TG cells, where 2-APB triggers a pronounced decay of the total SR-Ca 2+ leak, especially when compared to the antagonists' effect in WT (Fig. 8C) . In the latter, no differences to the control are detected whereas in the former a strong decrease in the basal SR-Ca 2+ leak is seen, indicative of increased IP 3 ICR under IP 3 R2-overexpression conditions. Now, in TG cells, an intuitively expected SR-Ca 2+ leak increase was virtually absent upon ET-1 stimulation. When compared to WT, in TG cells, tetracaine revealed a much smaller basal RyR2-dependent SR-Ca 2+ leak (Fig. 6 ). Under these specific conditions SERCA works close to the cytosolic steady-state [Ca 2+ ] (F 0 ) and thus, additional or excess IP 3 R-mediated SR-Ca 2+ leak is immediately compensated by SERCA activity. Because of the closed system (NCX block), cytosolic Ca 2+ levels above the steady-state (F 0 ) cannot be expected, as also shown by others (Shannon et al. 2002; Curran et al. 2007; Gonzalez et al. 2007; Santiago et al. 2010; Bers, 2014; Tzimas et al. 2017 responses that originate from CICR, and (2) identifying the specific contribution of IP 3 R2s in local and/or global Ca 2+ responses is impeded by a deficiency of highly selective pharmacological tools (Gafni et al. 1997; Bootman et al. 2002) . Although studies have fostered a contribution of IP 3 ICR on local Ca 2+ signalling in cardiomyocytes, the observation of individual functional interactions of Ca 2+ sparks and Ca 2+ puffs was just recently successful (Wullschleger et al. 2017) . In addition, immunocytochemistry largely failed to identify the precise localization of individual IP 3 R2s in mouse cardiac preparations, presumably because of limited antibody specificity. This limitation thus impedes the confirmation of the "rogue" IP 3 R2 function hypothesis (data not shown; Mohler et al. 2005; Kockskämper et al. 2008; Nakayama et al. 2010; Wullschleger et al. 2017) . J Physiol 596.18 Transgenic mouse models are sufficient and appropriate tools to examine regulatory mechanisms of CICR in cardiomyocytes. However, there is no doubt that a 1:1 extrapolation of findings emerging from animal studies to the human situation has to be critically evaluated. There are only a few studies comparing cellular remodelling situations in human cardiac disease with TG animal models used for specific aspects of cardiac remodelling both on global and cellular levels. Not only that, at present ECC under physiological conditions in human cardiomyocytes is only rudimentarily characterized (Signore et al. 2013) . The TG mouse model used in the present study reveals cardiac hypertrophy with several similarities to a human pathology. However, it was used as an appropriate tool to study a potential regulatory function of IP 3 ICR in CICR. A modulatory mechanism based on IP 3 -dependent SR-Ca 2+ leak has been unmasked by overexpression of IP 3 R2 which would otherwise have been potentially overlooked. Although several studies focus on IP 3 ICR as a potential pro-arrhythmogenic factor Proven et al. 2006) this model shows that higher expression of the IP 3 R2 might actually be beneficial for the preservation of ECC within pathology.
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